BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20972893)

  • 1. Does lactoferrin behave as an immunohistochemical oncofetal marker in bone and cartilage human neoplasms?
    Ieni A; Barresi V; Grosso M; Speciale G; Rosa MA; Tuccari G
    Pathol Oncol Res; 2011 Jun; 17(2):287-93. PubMed ID: 20972893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical evidence of lactoferrin in human embryo-fetal bone and cartilage tissues.
    Antonio I; Valeria B; Maddalena G; Giovanni T
    Cell Biol Int; 2010 Aug; 34(8):845-9. PubMed ID: 20443779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunolocalization of lactoferrin in cartilage-forming neoplasms.
    Ieni A; Barresi V; Grosso M; Rosa MA; Tuccari G
    J Orthop Sci; 2009 Nov; 14(6):732-7. PubMed ID: 19997820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactoferrin immuno-expression in human normal and neoplastic bone tissue.
    Ieni A; Barresi V; Grosso M; Rosa MA; Tuccari G
    J Bone Miner Metab; 2009; 27(3):364-71. PubMed ID: 19240970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoexpression of lactoferrin in bone metastases and corresponding primary carcinomas.
    Ieni A; Barresi V; Branca G; Giuffrè G; Rosa MA; Tuccari G
    Oncol Lett; 2013 May; 5(5):1536-1540. PubMed ID: 23761817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerostin expression in bone tumours and tumour-like lesions.
    Inagaki Y; Hookway ES; Kashima TG; Munemoto M; Tanaka Y; Hassan AB; Oppermann U; Athanasou NA
    Histopathology; 2016 Sep; 69(3):470-8. PubMed ID: 26896083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactoferrin in human tumours: immunohistochemical investigations during more than 25 years.
    Tuccari G; Barresi G
    Biometals; 2011 Oct; 24(5):775-84. PubMed ID: 21472415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chondroblastoma of bone. A clinical, radiological, light and immunohistochemical study.
    Edel G; Ueda Y; Nakanishi J; Brinker KH; Roessner A; Blasius S; Vestring T; Müller-Miny H; Erlemann R; Wuisman P
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(4):355-66. PubMed ID: 1384228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions.
    Shooshtarizadeh T; Rahimi M; Movahedinia S
    Pathol Res Pract; 2016 Oct; 212(10):876-879. PubMed ID: 27473669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogeny of lactoferrin in the developing mouse uterus: a marker of early hormone response.
    Newbold RR; Hanson RB; Jefferson WN
    Biol Reprod; 1997 May; 56(5):1147-57. PubMed ID: 9160713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical detection of lactoferrin of human milk in the tissues of the human and the fetus].
    Kazachkina NI; Kokhanova ID; Egorova SE; Nemtsova ER; Pugachev KK
    Arkh Anat Gistol Embriol; 1988 May; 94(5):19-23. PubMed ID: 3046571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovered on gastrointestinal stromal tumour 1 (DOG1): a useful immunohistochemical marker for diagnosing chondroblastoma.
    Akpalo H; Lange C; Zustin J
    Histopathology; 2012 Jun; 60(7):1099-106. PubMed ID: 22335248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YJ5 as an immunohistochemical marker of osteogenic lineage.
    Chua K; Virshup DM; Odono EG; Chang KTE; Tan NJH; Hue SS; Sim AYL; Lee VKM
    Pathology; 2021 Feb; 53(2):229-238. PubMed ID: 33187685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunohistochemical localization of bone Gla protein and osteonectin in normal human bone and cartilage tissues, and in osteosarcomas and chondrosarcomas].
    Chiba H; Matsuyama T
    Nihon Seikeigeka Gakkai Zasshi; 1993 May; 67(5):463-72. PubMed ID: 8336066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
    Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
    Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of leukemia inhibitory factor by cartilage-forming tumors of bone: an immunohistochemical study.
    Gouin F; Moreau A; Couillaud S; Guicheux J; Passuti N; Godard A; Heymann D
    J Orthop Res; 1999 Mar; 17(2):301-5. PubMed ID: 10221849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoexpression of lactoferrin in human sporadic renal cell carcinomas.
    Giuffrè G; Barresi V; Skliros C; Barresi G; Tuccari G
    Oncol Rep; 2007 May; 17(5):1021-6. PubMed ID: 17390038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis for Sox9 reveals the cartilaginous character of chondroblastoma and chondromyxoid fibroma of the bone.
    Konishi E; Nakashima Y; Iwasa Y; Nakao R; Yanagisawa A
    Hum Pathol; 2010 Feb; 41(2):208-13. PubMed ID: 19801163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical evidence of lactoferrin in hepatic biopsies of patients with viral or cryptogenetic chronic liver disease.
    Tuccari G; Villari D; Giuffrè G; Simone A; Squadrito G; Raimondo G; Barresi G
    Histol Histopathol; 2002 Oct; 17(4):1077-83. PubMed ID: 12371135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KPNA2 expression is a potential marker for differential diagnosis between osteosarcomas and other malignant bone tumor mimics.
    Jiang L; Liu J; Wei Q; Wang Y
    Diagn Pathol; 2020 Nov; 15(1):135. PubMed ID: 33176814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.